BCDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BioCardia Inc (BCDA) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks significant positive catalysts, has weak financial performance, and no clear trading signals from Intellectia Proprietary Trading Signals. While insider buying is a positive indicator, the company's poor financials and lack of recent news or analyst upgrades make it unsuitable for a long-term investment strategy.
The technical indicators for BCDA show a neutral trend. The MACD is slightly positive but contracting, RSI is neutral at 45.262, and moving averages are converging. The stock is trading below the pivot level of 1.236, with key support at 1.126 and resistance at 1.345. There are no strong bullish or bearish signals currently.
Insiders are buying, with a 373.20% increase in buying activity over the last month.
The company has weak financial performance, with no revenue growth, a significant drop in net income (-14.62% YoY), and a sharp decline in EPS (-60.66% YoY). Gross margin is at 0, indicating no profitability. Additionally, there is no recent news or significant trading trends from hedge funds.
In Q3 2025, the company reported no revenue growth, a net income drop of -14.62% YoY to -$1,483,000, and a sharp EPS decline of -60.66% YoY to -0.24. Gross margin dropped to 0, indicating no profitability.
No recent analyst ratings or price target changes are available for BCDA.
